Cat.#: ACPP-1216
| Despition | PARD3 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1662 | Human POFUT1 Protein (AC1662) | 5 µg | inquiry |
| ACPP-1367 | Myocilin Blocking Peptide (AC1367) | 250 µg | inquiry |
| ACPP-1226 | PDE7A Blocking Peptide (AC1226) | 250 µg | inquiry |
| ACPP-1836 | Human CHGA Protein (AC1836) | 5 µg | inquiry |
| ACPP-1657 | Human CRCP Protein (AC1657) | 5 µg | inquiry |
| ACPP-1136 | TYRO3 Blocking Peptide (AC1136) | 250 µg | inquiry |
| ACPP-1298 | Syndecan-1 Blocking Peptide (AC1298) | 250 µg | inquiry |
| ACPP-1015 | Recombinant Human ROR1 Protein (Fc Tag) (AC1015) | 50 µg | inquiry |
| ACPP-1463 | Human BCL2L11 Protein (AC1463) | 2 µg | inquiry |
| ACPP-1243 | ELOVL4 Blocking Peptide (AC1243) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.